The amino-terminal region of the beta2a subunit is the major element regulating Ca2+-dependent inactivation kinetics of L-type Ca2+ channels, suggesting splice variants can specifically modulate Ca2+ entry in heart and brain regions.
Answers are grounded in this paper and cite their sources.
Does not support changes in Ca2+ channel-targeted therapies; leaves open whether beta2a splice variants modulate Ca2+ entry in heart and brain.
Ca2+ channel auxiliary beta subunits have been shown to modulate voltage-dependent inactivation of various types of Ca2+ channels. The beta1 and beta2 subunits, that are differentially expressed with the L-type alpha1 Ca2+ channel subunit in heart, muscle and brain, can specifically modulate the Ca2+-dependent inactivation kinetics. Their expression in Xenopus oocytes with the alpha1C subunit leads, in both cases, to biphasic Ca2+ current decays, the second phase being markedly slowed by expression of the beta2 subunit. Using a series of beta subunit deletion mutants and chimeric constructs of beta1 and beta2 subunits, we show that the inhibitory site located on the amino-terminal region of the beta2a subunit is the major element of this regulation. These results thus suggest that different splice variants of the beta2 subunit can modulate, in a specific way, the Ca2+ entry through L-type Ca2+ channels in different brain or heart regions.
No takes yet. Share an insight, caveat, or question.
Cens et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: